Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape - Test2 - elhamkhani - TriplyDB

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

http://www.wikidata.org/entity/Q29620881

about

B7-H5 costimulates human T cells via CD28H Safety, activity, and immune correlates of anti-PD-1 antibody in cancer PD-L1 expression in human cancers and its association with clinical outcomes Towards tumor immunodiagnostics A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints The efficacy and potential predictive factors of PD-1/PD-L1 blockades in epithelial carcinoma patients: a systematic review and meta analysis NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Immunotherapy for cancer in the central nervous system: Current and future directions Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response Immunotherapy for lung cancer Clinical utility of nivolumab in the treatment of advanced melanoma The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response Advances in immunotherapy for melanoma PD-1/PD-L1 blockade in cancer treatment: perspectives and issues Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches Viro-immune therapy: A new strategy for treatment of pancreatic cancer Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression Predictive factors for immunotherapy in melanoma Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations New developments in the management of advanced melanoma - role of pembrolizumab The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment Antagonists of PD-1 and PD-L1 in Cancer Treatment Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy Adaptive Immune Resistance: How Cancer Protects from Immune Attack Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints Acquired and intrinsic resistance in cancer immunotherapy The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity Immunotherapy for prostate cancer: recent developments and future challenges PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence Immunotherapy advances for glioblastoma Immunotherapy in the treatment of non-small cell lung cancer Innate and adaptive immune cells in the tumor microenvironment The STING pathway and the T cell-inflamed tumor microenvironment New immunotherapies targeting the PD-1 pathway Immunotherapy for brain cancer: recent progress and future promise Individualising treatment choices in a crowded treatment algorithm

P2860

Q24295841-DC50CF09-5B60-4587-B307-AFB5B9984D45 Q24633070-7B2C7B5D-C982-4D13-ADB6-3600273E2070 Q26738361-C8A581FA-6980-4868-B21E-C6806FA6496D Q26738691-1ED92FD2-B07E-46CB-8345-888D8C600EFA Q26738729-780C4885-BA17-4383-A28F-5172688003D1 Q26740280-467AAD94-F830-436D-B794-29CB63C11480 Q26746478-58A471EF-6264-4639-926A-0E02BC56FAAA Q26750765-590E9397-FFF3-45F4-B773-435A95E1ACE7 Q26751029-F37921D0-3E3D-4996-8B0E-79C9EBA04CC2 Q26751254-F63E865F-8E5F-47F7-8B6B-E3F6F41B55A2 Q26751268-1A6E25B3-CCF7-48C9-B725-B2BA9B797252 Q26766066-4E3BDA06-20C3-457A-A1F1-254ABA35E7CC Q26768558-AA166346-D327-4EA1-BB86-E02BB9F00E2A Q26768641-F79C23D6-A2AD-4A62-8BE8-BCC21AC19C0B Q26769728-663D6FB2-C36D-4DA2-9F7F-A526D246DFCF Q26770492-2D7DFCF4-15BD-4B41-BF3D-5A298E205712 Q26774312-8BD4DDFC-87CD-4A3B-B962-C84FBAC718CF Q26774641-77586676-18D0-4A0B-8143-53CC4C2D1D04 Q26775189-1CD98F73-04A5-4F68-AC2A-B112570128D7 Q26778765-A52F1FB7-E201-4854-90ED-690C9FE19F10 Q26781038-A2E86946-196F-4D0E-BDA8-C117555E78CC Q26781931-504E1F87-897C-4380-9CDC-E7CCBBF102BA Q26796305-1B1C1E30-CA66-47C6-9CD3-71B3E6950EB9 Q26796311-F7933698-03A2-4E48-8FE3-116F4ED4B1C9 Q26798047-B11CC056-6B3A-4FC4-8922-989E37BD4452 Q26798404-B5AEFD52-8BD4-4886-8A9C-9E786D27AFD6 Q26798448-FF546BB7-6AB0-4D76-88B2-7934ED757972 Q26799073-26EDA60E-3C8E-4FB5-AD02-8C868B13B328 Q26801551-4F5D22BF-331C-4B49-AD5A-F2065074DCAE Q26827701-10741874-A923-4727-8A2D-6693FC12783A Q26829847-8F61CBF0-E84C-45A5-94AD-0E61B5389133 Q26852388-3D9EFFDF-1DB2-4992-B2EE-CDDF8D94DABE Q26865789-F56BA7AB-EF13-4A92-8AAB-BE302CBE8EDB Q26866513-342BF986-57EC-4CED-A149-E9CFA854B73F Q27000382-B2069538-E853-4202-91F4-74F44AF62197 Q27008342-8645DA03-8DA7-4EFA-A52A-999BABABB11B Q27008371-A453B1AD-51EB-4033-A942-D1941D78696F Q27010018-C0F67A87-ED3D-47A8-BD1A-C27F42177C5D Q27015881-17A9BB9C-1324-4AAC-B3E7-4CBB87BF0907 Q27023669-67C097FE-5B29-42F3-97B8-66F70E78C31B

P2860

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

http://www.wikidata.org/entity/Q29620881

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Colocalization of inflammatory ...... nce mechanism of immune escape

@ast

Colocalization of inflammatory ...... nce mechanism of immune escape

@en

type

label

Colocalization of inflammatory ...... nce mechanism of immune escape

@ast

Colocalization of inflammatory ...... nce mechanism of immune escape

@en

prefLabel

Colocalization of inflammatory ...... nce mechanism of immune escape

@ast

Colocalization of inflammatory ...... nce mechanism of immune escape

@en

P1433

Q29620881-8B2876FD-8295-4843-A7B9-12BAEDBCA28E

P1476

Q29620881-0B61F346-3067-4FDB-9A3B-48A2051EFA6E

P2093

Q29620881-1FB91B6C-3460-47BC-89A8-35FE76181705

Q29620881-41EF2937-9966-4FF7-9B3E-4A0E458FE4EA

Q29620881-51785C96-67C8-4AF3-A235-A433158526E4

Q29620881-66A204A4-F372-4736-8F65-47D0F3752097

Q29620881-6F8526A8-1707-45EF-86F3-C6D399D82138

Q29620881-7A2F7375-2BE5-4CEE-95EE-5F3F3CBA5164

Q29620881-852B657E-B59B-486B-86C1-C63820D68A2D

Q29620881-A0E91A91-76AE-4546-9647-3D1A3550ADD8

Q29620881-A7CD2167-E21E-456C-AD93-866ABC1C9301

Q29620881-FF633EFD-BF95-4368-89C5-498BBEFE6E73

P2860

Q29620881-00C68CA7-3F18-4215-BC91-8BEFCE6D13C7

Q29620881-039649E0-AD2E-45EA-BFC3-F16D4CEFD948

Q29620881-05DC2DB8-34B1-4388-80E0-050AE2328FC8

Q29620881-06A7C15F-2928-433B-B80A-645816A44C3E

Q29620881-0776BB3B-F74E-4F15-ADE1-4E9C16C64AB7

Q29620881-12E2897D-CD4A-4F34-A256-FB94A7F9270A

Q29620881-1C166747-C02B-4249-940C-1F2B30F8720C

Q29620881-1D33173E-F56A-4D86-BDDE-E7FBAE9CB15D

Q29620881-2689DB3F-72ED-492F-BA0E-F1F53DE12133

Q29620881-2C1F8038-3F33-4861-9F4E-A0750E228D04

P304

Q29620881-C5643E9F-BCB1-4B10-B9BC-0B985CE88139

P31

Q29620881-DEC9905E-6E42-44DB-81CA-3857B07D685C

P3181

Q29620881-40F1AAC4-3B11-4260-8761-FEEB6DE57F66

P356

Q29620881-4773AC3B-E9A7-428B-B1E7-1E0A84FF35E4

P407

Q29620881-725752D1-28B0-4C57-9AE5-C6E74C3FA0CA

P433

Q29620881-046B4A17-311A-4009-97E8-E22F08BB926C

P478

Q29620881-4C0F455B-C688-4DC2-9633-CF83E8039F0D

P50

Q29620881-E83E0D66-DFBB-4572-A4B7-BEBC918FB111

P577

Q29620881-703FDFD0-625D-418D-9E6B-0830E2B70D14

P5875

Q29620881-E9472957-45F1-4A4E-985A-586FC9207246

P698

Q29620881-BB3B4FC8-0BB2-46AF-AE6B-E91CFDF50EE7

P921

Q29620881-A137E739-EB17-4258-AC4A-0AA4D92EF2FC

P932

Q29620881-B43EAE4D-857F-4AA7-9C2A-25BFA07C0D55

P3181

P356

SCITRANSLMED.3003689

P1433

Science Translational Medicine

P1476

Colocalization of inflammatory ...... nce mechanism of immune escape

@en

P2093

Alison P Klein

http://www.w3.org/2001/XMLSchema#string

Drew M Pardoll

http://www.w3.org/2001/XMLSchema#string

Geoffrey D Young

http://www.w3.org/2001/XMLSchema#string

Haiying Xu

http://www.w3.org/2001/XMLSchema#string

Janis M Taube

http://www.w3.org/2001/XMLSchema#string

Lieping Chen

http://www.w3.org/2001/XMLSchema#string

Robert A Anders

http://www.w3.org/2001/XMLSchema#string

Shuming Chen

http://www.w3.org/2001/XMLSchema#string

Suzanne L Topalian

http://www.w3.org/2001/XMLSchema#string

Tracee L McMiller

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

P304

127ra37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

513009

http://www.w3.org/2001/XMLSchema#string

P356

10.1126/SCITRANSLMED.3003689

http://www.w3.org/2001/XMLSchema#string

P407

P433

127

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Rajni B. Sharma

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223990380

http://www.w3.org/2001/XMLSchema#string

P698

22461641

http://www.w3.org/2001/XMLSchema#string

P921

P932

3568523

http://www.w3.org/2001/XMLSchema#string